| NCT04995653 | A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT | COMPLETED | PHASE1 | 2021-11-24 | 2024-07-23 | 2024-07-23 |
| NCT03759041 | A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis | TERMINATED | PHASE2 | 2018-12-19 | 2021-10-13 | 2021-05-28 |
| NCT03183141 | ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection | COMPLETED | PHASE3 | 2017-10-23 | 2022-04-29 | 2022-04-29 |
| NCT03183128 | ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection | COMPLETED | PHASE3 | 2017-07-10 | 2020-09-29 | 2020-07-03 |
| NCT02830542 | SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence | COMPLETED | PHASE1 | 2016-08 | 2018-08 | 2018-05 |
| NCT02618187 | A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis | COMPLETED | PHASE1 | 2016-01-13 | 2018-01-26 | 2017-12-06 |
| NCT02437487 | SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) | COMPLETED | PHASE2 | 2015-05 | 2016-10 | 2016-07 |